| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/17/2001 | US6262075 Piperidone tachykinin antagonists |
| 07/17/2001 | US6262067 Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions |
| 07/17/2001 | US6262064 Octahydrobenzo[f]quinoline-based receptor agonists and antagonists |
| 07/17/2001 | US6262061 Treatment of panic attacks |
| 07/17/2001 | US6262057 Pseudopolymorphic forms of 2-[2-[4-[Bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride |
| 07/17/2001 | US6262056 Benzothiophene derivatives and corresponding use and composition |
| 07/17/2001 | US6262046 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 07/17/2001 | US6262045 Treatment of anxiety; sleep disorder; epilepsy; spasticity; muscle contracture or an extrapyramidal syndrom; inducing or maintaining anaesthesia |
| 07/17/2001 | US6262040 Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the production of tumor necrosis factor (TNF) |
| 07/17/2001 | US6262025 Their encoded protein products, as well as derivatives and analogs thereof. |
| 07/17/2001 | US6262024 Neuron regulatory factor for promoting neuron survival |
| 07/17/2001 | US6262021 Wounds of the skin, bone, mucus, tendons, muscles or connective tissue in mammals. |
| 07/17/2001 | US6261801 Nucleic acids encoding tumor necrosis factor receptor 5 |
| 07/17/2001 | US6261598 Carotenoid formulations, comprising a mixture of B-carotens, lycopene and lutein |
| 07/17/2001 | US6261565 Plant extract |
| 07/17/2001 | US6261544 Poly(hydroxy acid)/polymer conjugates for skin applications |
| 07/17/2001 | CA2160961C New tricyclic amide compounds, process for preparing the same and pharmaceutical compositions containing them |
| 07/17/2001 | CA2157860C 5,6-dihydro-4h-imidazo [4,5,1-ij] quinolines, processes for their preparation, their use as medicaments, and intermediate compounds |
| 07/12/2001 | WO2001050134A2 Methods of detection of amyloidogenic proteins |
| 07/12/2001 | WO2001049740A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | WO2001049715A2 Methods and compositions for inhibiting neoplastic cell growth |
| 07/12/2001 | WO2001049711A2 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | WO2001049703A2 Substituted sapogenins and their use |
| 07/12/2001 | WO2001049690A1 9-azabicyclo[4.2.1]non-2-ene derivatives as ligands for nicotinic acetylcholine receptors |
| 07/12/2001 | WO2001049689A2 NOVEL SUBSTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM |
| 07/12/2001 | WO2001049687A2 Cyclohexene nucleic acids |
| 07/12/2001 | WO2001049684A1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 07/12/2001 | WO2001049683A1 Novel heteroaryl derivatives, their preparation and use |
| 07/12/2001 | WO2001049680A1 Novel indole derivatives |
| 07/12/2001 | WO2001049679A1 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives |
| 07/12/2001 | WO2001049678A1 Substituted phenyl-piperazine derivatives, their preparation and use |
| 07/12/2001 | WO2001049677A1 Phenylpiperazinyl derivatives |
| 07/12/2001 | WO2001049676A1 Substituted piperidines, medicaments containing these compounds, and methods for the production thereof |
| 07/12/2001 | WO2001049674A2 Glycosidase inhibitors and preparation thereof |
| 07/12/2001 | WO2001049673A2 Compounds and methods for modulation of estrogen receptors |
| 07/12/2001 | WO2001049670A1 5,10-dihydroacridines as calcium channel blockers |
| 07/12/2001 | WO2001049661A1 5-THIA-φ-(SUBSTITUTED PHENYL)-PROSTAGLANDIN E ALCOHOLS, PROCESS FOR PREPARING THE ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT |
| 07/12/2001 | WO2001049654A2 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 07/12/2001 | WO2001049651A2 Aminomethyl-phenyl-cyclohexanone derivatives |
| 07/12/2001 | WO2001049650A1 Novel esters derived from (rr,ss)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl |
| 07/12/2001 | WO2001049638A2 A process for converting stereoisomers of sertraline into sertraline |
| 07/12/2001 | WO2001049321A1 Tnf inhibitors for the treatment of neurological, retinal and muscular disorders |
| 07/12/2001 | WO2001049312A2 O-superfamily conotoxin peptides |
| 07/12/2001 | WO2001049309A2 Combinations of growth factors and i: upa or i: mmp for the treatment of damaged tissue |
| 07/12/2001 | WO2001049307A1 Catechins and green tea extract for the treatment of amyloidosis in alzheimer's disease and other amyloidoses |
| 07/12/2001 | WO2001049305A2 Process for obtaining thylakoids from plants, pure thylakoids and use thereof |
| 07/12/2001 | WO2001049303A1 Multivalent electron active compositions and methods of making and using same |
| 07/12/2001 | WO2001049302A1 Compositions and methods for facilitating skin growth and managing skin conditions |
| 07/12/2001 | WO2001049301A1 Methods of using electron active compounds for managing cancer |
| 07/12/2001 | WO2001049292A1 Oral mucosal dosage forms of apomorphine |
| 07/12/2001 | WO2001049286A1 Method and formulation for treating resistance to antihypertensives and related conditions |
| 07/12/2001 | WO2001049281A2 POLYHYDROXYLATED AROMATIC COMPOUNDS FOR THE TREATMENT OF AMYLOIDOSIS AND α-SYNUCLEIN FIBRIL DISEASES |
| 07/12/2001 | WO2001049275A2 Methods and compositions for mitigating pain using nitrate esters |
| 07/12/2001 | WO2001049270A2 Odor-masking coating for a pharmaceutical preparation |
| 07/12/2001 | WO2001049163A1 Pp14 fusion proteins and methods for making and using the same |
| 07/12/2001 | WO2001044207A8 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 07/12/2001 | WO2001004113A3 Process for the preparation of paroxetine and synthetic intermeditates thereof |
| 07/12/2001 | WO2001002358A3 Cyclized amide derivatives for treating or preventing neuronal damage |
| 07/12/2001 | WO2001001956A3 Solid preparations containing paroxetine |
| 07/12/2001 | WO2000078697A3 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof |
| 07/12/2001 | WO2000074724A3 Conjugates comprising cytokines and nucleic acids for treating proliferating cells |
| 07/12/2001 | WO2000055318A8 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 07/12/2001 | WO2000005223A3 Heterocyclic derivatives and their use as integrin inhibitors |
| 07/12/2001 | WO2000000510A3 Growth factor modulators |
| 07/12/2001 | US20010007873 Compounds such as 4-(6-amino-pyridin-2-yl)-3-methoxyphenol as nitric oxide synthase inhibitors used to treat central nervous system disorders, inflammatory disorders, septic shock, etc... |
| 07/12/2001 | US20010007869 Alpha-substittuted pyridazino quinoline compounds |
| 07/12/2001 | US20010007862 Aqueous solution of cyclodextrin |
| 07/12/2001 | US20010007856 Method for preventing and treating at a superacute phase, against neurological deficits or neuronal death in brain ischemia and pathological conditions |
| 07/12/2001 | US20010007758 Administering mixture of synthetic polypeptides |
| 07/12/2001 | US20010007680 Use of a film coating as taste-masking coating of oral dosage forms |
| 07/12/2001 | US20010007662 Aqueous formulation suitable for lyophilization; biologically active form of nerve growth factor with bulking agent, buffer and water |
| 07/12/2001 | US20010007657 Providing compound that binds to epidermal growth factor receptor in order to attract glial progenitor cells (or progeny) to site in central nervous system in need of repair |
| 07/12/2001 | DE19963868A1 Neue substituierte Piperidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung New substituted piperidines, pharmaceutical compositions containing them and methods for their preparation |
| 07/12/2001 | DE19963179A1 Substituierte 1- und 2-Naphthol-Mannichbasen Substituted 1- and 2-naphthol Mannich bases |
| 07/12/2001 | DE19963175A1 Verwendung von substituierten 4-Amino-1-phenylbutan-2-ol-Verbindungen als Arzneimittel Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments |
| 07/12/2001 | DE19963174A1 Substituierte Pyrrol-Mannichbasen Substituted pyrrole Mannich bases |
| 07/12/2001 | DE19960154A1 Flache Arzneizubereitung zur transmucosalen Verabreichung von Oxycodon oder einem vergleichbaren Wirkstoff in der Mundhöhle, für die Anwendung in der Schmerztherapie und Suchttherapie Flat pharmaceutical preparation for transmucosal administration of oxycodone or a similar drug in the oral cavity, for use in the treatment of pain and addiction treatment |
| 07/12/2001 | DE10000739A1 New piperidine and piperazine derivatives which are antagonists of certain serotonin receptors, are useful in treatment of, e.g. eating disorders, stroke, anxiety or Parkinson's disease |
| 07/12/2001 | DE10000312A1 Substituierte Aminomethyl-Phenyl-Cyclohexanderivate Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 07/12/2001 | DE10000311A1 Aminomethyl-Phonyl-Cyclohexanonderivate Aminomethyl-Phonyl-cyclohexanone derivatives |
| 07/12/2001 | CA2396688A1 Glycosidase inhibitors and methods of synthesizing same |
| 07/12/2001 | CA2396529A1 O-superfamily conotoxin peptides |
| 07/12/2001 | CA2396401A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | CA2396315A1 Novel substituted pyrazolo[4,3-e]diazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them |
| 07/12/2001 | CA2396310A1 Aminomethyl-phenyl-cyclohexanone derivatives |
| 07/12/2001 | CA2396304A1 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 07/12/2001 | CA2396059A1 Compounds and methods for modulation of estrogen receptors |
| 07/12/2001 | CA2395984A1 Novel heteroaryl derivatives, their preparation and use |
| 07/12/2001 | CA2395976A1 Novel esters derived from (rr,ss)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl |
| 07/12/2001 | CA2395876A1 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | CA2395867A1 Phenylpiperazinyl derivatives |
| 07/12/2001 | CA2395695A1 Catechins and green tea extract for the treatment of amyloidosis in alzheimer's disease and other amyloidoses |
| 07/12/2001 | CA2395606A1 Novel indole derivatives |
| 07/12/2001 | CA2395487A1 Composition for the treatment of damaged tissue |
| 07/12/2001 | CA2395198A1 Pp14 fusion proteins and methods for making and using the same |
| 07/12/2001 | CA2394297A1 Oral mucosal dosage forms of apomorphine |
| 07/12/2001 | CA2394199A1 5,10-dihydroacridines as calcium channel blockers |
| 07/12/2001 | CA2394184A1 Methods and compositions for mitigating pain using nitrate esters |
| 07/12/2001 | CA2393942A1 Odor-masking coating for a pharmaceutical preparation |
| 07/11/2001 | EP1114823A2 Substituted benzylamino nitrogen containing non-aromatic heterocycles |